National Institute of Allergy & Infectious Diseases: Study Vaccine Protects Monkeys Against Four Types of Hemorrhagic Fever Viruses
November 08, 2019
November 08, 2019
WASHINGTON, Nov. 8 -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release:
Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa. The University of Texas Medical Branch in Galveston and Profectus BioSciences of New York are developing . . .
Scientists funded by the National Institutes of Health have developed an investigational vaccine that protected cynomolgus macaques against four types of hemorrhagic fever viruses endemic to overlapping regions in Africa. The University of Texas Medical Branch in Galveston and Profectus BioSciences of New York are developing . . .